Catalysts for Samsung Bioepis Co Ltd
65 tracked
Jun 26, 2019
approval
RENFLEXIS (INFLIXIMAB-ABDA) — FDA approval
infliximab biosimilar
→
Apr 25, 2019
approval
ETICOVO (ETANERCEPT-YKRO) — FDA approval
ETICOVO
→
Mar 21, 2019
approval
RENFLEXIS (INFLIXIMAB-ABDA) — FDA approval
infliximab biosimilar
→
Jan 18, 2019
approval
ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approval
ONTRUZANT
→
Apr 21, 2017
approval
RENFLEXIS (INFLIXIMAB-ABDA) — FDA approval
infliximab biosimilar
→